Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer
2014 · World Journal of Surgical Oncology · 40 citations
https://doi.org/10.1186/1477-7819-12-290
T
Tong Meng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
174
Papers
5.6K
Citations
33
h-index
85
i10-index
Tong Meng is an academic researcher from Roche (United States). The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Bone Tumor Diagnosis and Treatments & RNA modifications and cancer. The author has an h-index of 33, co-authored 148 publications.
ORCID: 0000-0001-6403-1357Papers by this author
worksHuman HDAC6 senses valine abundancy to regulate DNA damage
2024 · Nature · 34 citations
https://doi.org/10.1038/s41586-024-08248-5
En bloc resection for treatment of tumor-induced osteomalacia: a case presentation and a systematic review
2015 · World Journal of Surgical Oncology · 28 citations
https://doi.org/10.1186/s12957-015-0589-3
Roles of ubiquitination in the crosstalk between tumors and the tumor microenvironment (Review)
2022 · International Journal of Oncology · 23 citations
https://doi.org/10.3892/ijo.2022.5374
Factors associated with improved survival following surgical treatment for metastatic prostate cancer in the spine: retrospective analysis of 29 patients in a single center
2016 · World Journal of Surgical Oncology · 22 citations
https://doi.org/10.1186/s12957-016-0961-y
Spine extra-osseous chordoma mimicking neurogenic tumors: report of three cases and review of the literatures
2016 · World Journal of Surgical Oncology · 18 citations
https://doi.org/10.1186/s12957-016-0951-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat